Jazz Pharma Broadens Its Prospects in Epilepsy With Deal for Selective Saniona Drug

Saniona’s drug candidate could expand Jazz Pharmaceuticals portfolio in epilepsy. But this preclinical small molecule will need to show advantages in safety and efficacy to compete with Biohaven Pharmaceuticals and Xenon Pharmaceuticals, each with clinical-stage drugs that hit the same epilepsy target. The post Jazz Pharma Broadens Its Prospects in Epilepsy With Deal for Selective…

Read More

Ingrid Lindberg, Sobrynth

Ingrid is one of the OGs of customer service in health plans, PBMs and as she insists startups. She and her co-founder Marin Nelson have built Sobrynth–a company that is taking a whole new approach to helping with (primarily) alcohol addiction in the workplace. Despite the rise of mental health solutions, EAP, the focus on…

Read More

Alcohol: Changing use and perceptions

Conventional wisdom holds that alcohol use is part of American culture…but perhaps this is changing. According to a Gallup poll released last week, not only is alcohol use declining but there is an increasing perception that alcohol use is not good for you. While a majority of Americans (54%) still use alcohol, drinking rates are…

Read More